Plant Extract Powder
S-Equol Powder
S-Equol is a key metabolite of soy isoflavones produced by gut microbiota. It acts as a selective estrogen receptor modulator with high selectivity for estrogen receptor beta. Available as a white to light-yellow powder with purity ≥98%. It is directly ab
Description
How does S-Equol serve as a selective ERβ agonist to support menopause management and healthy aging?
S-Equol acts as a highly selective agonist for the Estrogen Receptor beta (ERβ), specifically targeting tissues such as the brain, bones, and skin. It helps provide gentle relief from occasional menopausal discomforts, such as hot flashes and sleep disturbances, while supporting the maintenance of healthy bone density. Importantly, it exhibits minimal binding affinity for the Estrogen Receptor alpha (ERα) associated with breast and uterine tissues. This selective mechanism allows it to offer effective healthy aging support while mitigating the potential risks often associated with traditional hormone replacement therapies.
| Test Item | Standard |
| Appearance | White powder |
| Purity | NLT 99% |
| Mesh size | 100% pass 100 mesh |
| Melting point | 189-190℃ |
| Optical rotation | [α]D<(-)21°（c=5.0g/l, ethanol） |
| Loss on drying | NMT 1% |
| Residual solvent (ethanol) | NMT 200 ppm |
| Arsenic | NMT 1.0 ppm |
| Lead | NMT 1.0 ppm |
| Mercury | NMT 1.0 ppm |
| Cadmium | NMT 1.0 ppm |
| Total Heavy Metals | NMT 10.0 ppm |
| Total Viable Aerobic Count | NMT 1000 CFU/g |
| Total Yeast and Mold Count | NMT 100 CFU/g |
| Total Coliform | NMT 100 CFU/g |
| Salmonella | Negative |
| S. aureus | Negative |
| E. coli | Negative |
1. Menopause & Daily Health Management
S-Equol is a core botanical ingredient designed to support systemic health during the hormonal transitions of menopause. In dietary supplements, it is widely used to help manage occasional menopausal discomforts, such as hot flashes, night sweats, mood fluctuations, and sleep disturbances. Additionally, it supports bone density maintenance by regulating bone metabolism and promotes cardiovascular wellness by supporting healthy arterial elasticity and balanced lipid profiles.
2. Nutricosmetics & Skin Anti-aging
In the "nutricosmetics" sector, S-Equol is highly valued as a premium oral ingredient for skin anti-aging, thanks to its highly selective activation of the ERβ receptor. Clinical research indicates that oral S-Equol can help improve the appearance of crow's feet (area and depth), enhance skin hydration, and support epidermal barrier homeostasis, thereby promoting a youthful and healthy complexion.
3. Precision Nutrition & Synergistic Formulations
S-Equol frequently serves as a foundational "homeostatic modulator" in complex nutritional formulations. For example, it is often scientifically combined with ingredients like inositol, vitex (chasteberry) extract, hops extract, or urolithin A. This synergistic approach supports hormonal signaling, ovarian health, and circadian rhythm balance, meeting the modern demand for precise and personalized women's health management.
4. Men's Health & Prostate Support
Beyond women's health, S-Equol also exhibits the ability to bind and modulate the activity of dihydrotestosterone (DHT). Consequently, it is utilized in men's health supplements to support prostate health and maintain healthy hair growth, offering a natural alternative with a favorable safety profile compared to traditional anti-androgen approaches.
5. Pharmaceutical R&D & Scientific Research
In pharmaceutical and scientific research, high-purity S-Equol (e.g., 99% purity) serves as a high-affinity ligand for the Estrogen Receptor beta (ERβ). It is extensively used as a research reagent in cell and animal studies to investigate its potential in modulating prostate cell growth, supporting islet cell function, and exploring its mechanisms in healthy aging and metabolic regulation.
1.Natural Source & Precision Supplementation: As a natural metabolite of soy isoflavones, direct supplementation bypasses individual variations in gut microbiome conversion, ensuring consistent and stable absorption of the active compounds.
2.Highly Selective Modulation: It exhibits a high binding affinity for Estrogen Receptor beta (ERβ) while showing minimal affinity for ERα. This allows for gentle modulation while significantly reducing the risk of overstimulation in breast and uterine tissues.
3.Exceptional Bioavailability: Compared to its precursor soy isoflavones, it features lower molecular polarity, resulting in superior gastrointestinal absorption and enhanced blood-brain barrier permeability for faster and more effective delivery.
4.Non-hormonal Safety Profile: As a non-steroidal, non-hormonal small molecule, it functions through "signal modulation" rather than "hormone replacement." This makes it a gentle and highly suitable option for long-term daily use.
Q1: What is S-Equol and why is it considered safer than traditional phytoestrogens?
A: S-Equol is a natural, bioactive metabolite produced in the human gut through the bacterial metabolism of soy isoflavones. Its unique advantage lies in its "high selectivity." It specifically binds to and activates Estrogen Receptor beta (ERβ), which supports bone, vascular, and skin health. Conversely, it exhibits minimal binding affinity for Estrogen Receptor alpha (ERα), which is associated with tissue proliferation risks in the breast and uterus. Consequently, it offers a safer and gentler alternative to traditional phytoestrogens.
Q2: Since soy foods contain soy isoflavones, why is direct S-Equol supplementation necessary?
A: It comes down to individual differences. Scientific research indicates that only about 30% to 50% of the global population possesses the specific gut microbiota required to convert soy isoflavones into Equol. This means that even with a high intake of soy-based foods, many individuals may not absorb this active compound. Direct S-Equol supplementation bypasses this gut microbiome conversion bottleneck, ensuring that everyone can consistently obtain stable and adequate amounts of the active ingredient.
Q3: What clinically verified benefits does S-Equol primarily offer?
A: The most concentrated clinical evidence supports its role in managing menopausal symptoms. Multiple double-blind clinical trials have demonstrated that a daily supplementation of 10 mg of S-Equol can significantly reduce the frequency and severity of hot flashes and night sweats, while also improving neck and shoulder stiffness and sleep quality. Furthermore, clinical studies show positive outcomes in reducing skin wrinkles in postmenopausal women, supporting the maintenance of bone density, and improving arterial stiffness to support cardiovascular health.
